| Company Name: |
Yichang Zhongyitai Trading Co., Ltd.
|
| Tel: |
0717-6449896 13886658719 |
| Email: |
root@zhongyitai.com |
| Products Intro: |
Product Name:Hexanoyl-L-erythro-sphingosine
CAS:189894-78-8
Purity:98+% Package:1mg
|
| Company Name: |
Alfa Chemistry
|
| Tel: |
1-516-6625404 |
| Email: |
support@alfa-chemistry.com |
| Products Intro: |
Product Name:Hexanoyl-L-erythro-sphingosine
CAS:189894-78-8
Purity:99%+ Package:1g;10g;100g;1KG;5KG
|
| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:C6 L-erythro Ceramide (d18:1/6:0)
CAS:189894-78-8
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:C6 L-erythro Ceramide (d18:1/6:0)
CAS:189894-78-8
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
|
| | C6 L-erythro Ceramide (d18:1/6:0) Basic information |
| Product Name: | C6 L-erythro Ceramide (d18:1/6:0) | | Synonyms: | C6 L-erythro Ceramide (d18:1/6:0);Hexanoyl-L-erythro-sphingosine;Hexanamide, N-[(1R,2S,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-;N-[(1R,2S,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-hexanamide | | CAS: | 189894-78-8 | | MF: | C24H47NO3 | | MW: | 397.63 | | EINECS: | | | Product Categories: | | | Mol File: | 189894-78-8.mol |  |
| | C6 L-erythro Ceramide (d18:1/6:0) Chemical Properties |
| Boiling point | 574.7±50.0 °C(Predicted) | | density | 0.946±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Chloroform: Soluble; DMF: 5 mg/ml; DMSO: Soluble; Ethanol: Soluble | | form | A solid | | pka | 13.53±0.20(Predicted) |
| | C6 L-erythro Ceramide (d18:1/6:0) Usage And Synthesis |
| Description | C6 L-erythro Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides.1,2 It is metabolized by ceramide glucosyltransferase to form C6 L-erythro glucosylceramide. C6 L-erythro Ceramide is cytotoxic to U937 cells (IC50 = 18 μM).3 | | References | 1. Schwarz, A., and Futerman, A.H. Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth J. Neurosci. 17(9),2929-2938(1997).
2. Paul, P., Kamisaka, Y., Marks, D.L., et al. Purification and characterization of UDP-glucose: Ceramide glucosyltransferase from rat liver Golgi membranes Curr. Opin. Struct. Biol. 271(4),2287-2293(1996).
3. Chang, Y.-T., Choi, J., Ding, S., et al. The synthesis and biological characterization of a ceramide library J. Am. Chem. Soc. 124(9),1856-1857(2002). |
| | C6 L-erythro Ceramide (d18:1/6:0) Preparation Products And Raw materials |
|